{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:58Z","timestamp":1791176878078,"version":"4.1.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,3]]},"DOI":"10.1093\/jnci\/djt032","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T23:50:32Z","timestamp":1363218632000},"page":"469-474","source":"Crossref","is-referenced-by-count":126,"title":["Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study"],"prefix":"10.1093","volume":"105","author":[{"given":"Amy","family":"Leval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herweijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ploner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fridman Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Netterlid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Spar\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisen","family":"Arnheim-Dahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"issue":"10","key":"key\n\t\t\t\t20170520213840_CIT0001","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"issue":"6","key":"key\n\t\t\t\t20170520213840_CIT0002","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"issue":"6","key":"key\n\t\t\t\t20170520213840_CIT0003","doi-asserted-by":"crossref","first-page":"19119","DOI":"10.2807\/ese.14.06.19119-en","article-title":"Introduction of human papillomavirus (HPV) vaccination in Sweden","volume":"14","author":"Tegnell","year":"2009","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170520213840_CIT0004","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"key\n\t\t\t\t20170520213840_CIT0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2011.185","article-title":"End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24\u201345 years of age","volume":"105","author":"Castellsague","year":"2011","journal-title":"Br J Cancer"},{"issue":"19","key":"key\n\t\t\t\t20170520213840_CIT0006","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20170520213840_CIT0007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"key\n\t\t\t\t20170520213840_CIT0008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"key\n\t\t\t\t20170520213840_CIT0009","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Inf"},{"issue":"5","key":"key\n\t\t\t\t20170520213840_CIT0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007\u20132010","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Pub Health"},{"issue":"3","key":"key\n\t\t\t\t20170520213840_CIT0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/infdis\/jir287","article-title":"Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs","volume":"204","author":"Castle","year":"2011","journal-title":"J Infect Dis"},{"issue":"11","key":"key\n\t\t\t\t20170520213840_CIT0012","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/652404","article-title":"Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"key\n\t\t\t\t20170520213840_CIT0013","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20170520213840_CIT0014","volume-title":"International Classification of Disease, Tenth Revision","author":"World Health Organization","year":"2010"},{"key":"key\n\t\t\t\t20170520213840_CIT0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Pub Health"},{"issue":"9679","key":"key\n\t\t\t\t20170520213840_CIT0016","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial","volume":"373","author":"Munoz","year":"2009","journal-title":"Lancet"},{"issue":"19","key":"key\n\t\t\t\t20170520213840_CIT0017","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20170520213840_CIT0018","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjc.6603927","article-title":"Public awareness that HPV is a risk factor for cervical cancer","volume":"97","author":"Marlow","year":"2007","journal-title":"Br J Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170520213840_CIT0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4161\/hv.3.5.4310","article-title":"Trust and experience as predictors of HPV vaccine acceptance","volume":"3","author":"Marlow","year":"2007","journal-title":"Hum Vaccin"},{"issue":"2","key":"key\n\t\t\t\t20170520213840_CIT0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ijc.24712","article-title":"Attitudes to HPV vaccination among parents of children aged 12\u201315 years\u2014a population-based survey in Sweden","volume":"126","year":"2010","journal-title":"Int J Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/105\/7\/469\/17313042\/djt032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T06:45:22Z","timestamp":1644561922000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djt032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,3,7]]},"published-print":{"date-parts":[[2013,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djt032","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,7]]}}}